impact of recession on your business
Autoimmune disease market

Autoimmune Disease Market Size, Share & Segmentation By Product (Consumables and Assay Kits Instruments ),By Test type (Laboratory Tests, Inflammatory Markers Autoantibodies & Immunologic tests ), By Disease Type(Systematic Autoimmune Disease, Localize Autoimmune Disease) By End User (Clinical Laboratories, Hospitals)

Report Id: SNS/HC/2666 | January 2023 | Region: Global | 130 Pages

Report scope & Overview

Autoimmune Disease Market was valued at USD 1099 million in 2022 and is expected to reach USD 1791 million by 2030, and grow at a CAGR of 6.3% over the forecast period of 2023-2030. The autoimmune disease global market is expected to grow because of the rise in awareness of this disease, in autoimmune disease the production of antibodies tends to happen which attacks its healthy tissues. Experts say that during autoimmune disease the immune system fails to detect abnormality in the tissues or any other part of the body, abnormality in the functioning of the immune system is the biggest concerning factor. There is no proper information about what triggers autoimmune diseases so genes are one of the main reasons behind the cause of autoimmune diseases. In autoimmune disease, the healthy tissues can’t predict the difference between the healthy tissues and the tissues which are unhealthy or let’s say which don’t deserve to be the in the body which results in the attack on healthy cells which leads to many issues and severe health concerns.

Autoimmune Disease Market Bar Graph

Impact of covid 19

As we all know covid 19 affected each and every industry due to major issues like the strict rules imposed by the government. Covid 19 had a negative impact on the Autoimmune disease global market. The reasons include the disruption of supply chain management all around the globe as resources were not available which led to stop in production, and due to the fear of covid 19 patients didn’t visited hospitals on a regular basis, according to the data patients showed up to the hospital only in emergency cases. Also, the priority for the healthcare industry was to focus on covid patients which also had a negative impact on autoimmune disease global market.

Market Dynamics

Drivers

  • Rise in autoimmune diseases all around the globe

  • Increase of awareness in people for autoimmune diseases

Restrains

  • Unavailability of capital for setting up the diagnostic centers

Opportunity

  • Overall increase in technological advancement in the healthcare industry.

  • Support from the government for the autoimmune disease market and the favorable initiative taken by them.

Challenge

  • Time consumable process including test results

  • Uncertainty about the accuracy of results.

Impact of Russia Ukraine war

The Russia-Ukraine war had an overall negative impact on the healthcare industry, due to the conditions in that region it has become very hard for the investors to invest in that region and also nations  economic conditions gets affected during such situations .Autoimmune disease market may get negatively affected due to infrastructure loss caused by war, The unavailability of products and materials important for the autoimmune disease market also may get affected due to the disruption of global supply chain route.

Impact of ongoing recession

Recession will have a negative impact on the autoimmune global disease market due to the economic conditions worldwide. Experts say that during recession people’s  perception towards health change, as people will not focus on treating the disease at the early stage due to the hospital expense, and people ignore the small symptoms. The cases of emergency patients will increase compared to regular check-ups and the only reason behind that is the instability of economic conditions. Also, there will be fluctuation in prices due to the rise in prices of other factors which co-relate with autoimmune diseases market such as transportation, taxes, government regulations and many more .

Regional analysis

Reports declare that  Europe has the largest market share for autoimmune disease global market,

The driving factors include the rise in the disease due to the unhealthy lifestyle, the rise in the increase of aged population which leads to issues like weak immune system.

Asia Pacific is also considered to the fastest-growing region after Europe in the autoimmune disease market.

By Product

  • Consumables and Assay Kits

  • Instruments

By Test Type

  • Laboratory Tests

  • Inflammatory Markers

  • Autoantibodies & Immunologic tests

By Disease Type

  • Systematic Autoimmune Disease

  • Localize Autoimmune Disease

By End User

  • Clinical Laboratories

  • Hospitals

Autoimmune Disease Market Segment Chart

Key Players

The major Key players are Siemens, Abbott, Thermos, Fisher Scientific, Danaher, Bio-Rad Laboratories, Grifols, Trinity Biotech Werfen, Kronus,  Cambridge life Sciences Limited, HTG Molecular Diagnostics


Frequently Asked Questions (FAQ) :

The market size for 2022 for this market is USD 1099 million.

Rise in autoimmune diseases all around the globe

1. Time consumable process including test results

2. Uncertainty about the accuracy of results

Focus on covid patients during covid 19  had a negative impact on the autoimmune disease global market

Autoimmune disease market is divided into 4 segments By Product Type, By Test Type, By Disease Type and By End User.


Table of Contents

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia War

4.3 Impact of Current Ongoing Recession

4.3.1 Introduction

4.3.2 Impact on Major Economies

4.3.2.1 US

4.3.2.2 Canada

4.3.2.3 Germany

4.3.2.4 France

4.3.2.5 United Kingdom

4.3.2.6 China

4.3.2.7 Japan

4.3.2.8 South Korea

4.3.2.9 Rest of The World

 

5. Value Chain Analysis

 

6. Porter’s 5 Forces Model

 

7. PEST Analysis

 

8.Autoimmune Disease Market Segmentation, By Product Type

8.1 Consumables and Assay Kits

8.2 Instruments

 

9.Autoimmune Disease Market Segmentation, By Test Type

9.1 Laboratory Tests

9.2 Inflammatory Markers

9.3 Autoantibodies & Immunologic Tests

 

10. Autoimmune Disease Market Segmentation, By Disease Type

10.1 Systematic Autoimmune Disease

10.2 Localize Autoimmune Disease

 

11 Autoimmune Disease Market Segmentation, By End User

11.1 Clinical Laboratories

11.2 Hospitals

 

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.1.1 USA Autoimmune Disease Market by Product Type

12.2.1.2 USA Autoimmune Disease Market by Test

12.2.1.2 USA Autoimmune Disease Market by Disease Type

12.2.1.3 USA Autoimmune Disease Market by End User

12.2.2 Canada

12.2.2.1 Canada Autoimmune Disease Market by Product Type

12.2.2.2 Canada Autoimmune Disease Market by Test Type

12.2.2.2 Canada Autoimmune Disease Market by Disease Type

12.2.2.3 Canada Autoimmune Disease Market by End User

12.2.3 Mexico

12.2.3.1 Mexico Autoimmune Disease Market by Product Type

12.2.2.2 Canada Autoimmune Disease Market by Test Type

12.2.3.3 Mexico Autoimmune Disease Market by Disease Type

12.2.3.4 Mexico Autoimmune Disease Market by End User

12.3 Europe

12.3.1 Germany

12.3.1.1 Germany Autoimmune Disease Market by Product Type

12.3.1.2 Germany Autoimmune Disease Market by Test Type

12.3.1.3 Germany Autoimmune Disease Market by Disease Type

12.3.1.4 Germany Autoimmune Disease Market by End User

12.3.2 UK

12.3.2.1 UK Autoimmune Disease Market by Product Type

12.3.2.2 UK Autoimmune Disease Market by Test Type

12.3.2.3 UK Autoimmune Disease Market by Disease Type

12.3.2.4 UK Autoimmune Disease Market by End User

12.3.3 France

12.3.3.1 France Autoimmune Disease Market by Product Type

12.3.3.2 France Autoimmune Disease Market by Test Type

12.3.3.3 France Autoimmune Disease Market by Disease Type

12.3.3.4 France Autoimmune Disease Market by End User

12.3.4 Italy

12.3.4.1 Italy Autoimmune Disease Market by Product Type

12.3.4.2 Italy Autoimmune Disease Market by Test Type

12.3.4.3 Italy Autoimmune Disease Market by Disease Type

12.3.4.4 Italy Autoimmune Disease Market by End User

12.3.5 Spain

12.3.5.1 Spain Autoimmune Disease Market by Product Type

12.3.5.2 Spain Autoimmune Disease Market by Test Type

12.3.5.3 Spain Autoimmune Disease Market by Disease Type

12.3.5.4 Spain Autoimmune Disease Market by End User

12.3.6 The Netherlands

12.3.6.1 Netherlands Autoimmune Disease Market by Product Type

12.3.6.2 Netherlands Autoimmune Disease Market by Test Type

12.3.6.3 Netherlands Autoimmune Disease Market by Disease Type

12.3.6.4 Netherlands Autoimmune Disease Market by End User

12.3.7 Rest of Europe

12.3.7.1 Rest of Europe Autoimmune Disease Market by Product Type

12.3.7.2 Rest of Europe Autoimmune Disease Market by Test Type

12.3.7.3 Rest of Europe Autoimmune Disease Market by Disease Type

12.3.7.4 Rest of Europe Autoimmune Disease Market by End User

12.4 Asia-Pacific

12.4.1 Japan

12.4.1.1 Japan Autoimmune Disease Market by Product Type

12.4.1.2 Japan Autoimmune Disease Market by Test Type

12.4.1.3 Japan Autoimmune Disease Market by Disease Type

12.4.1.4 Japan Autoimmune Disease Market by End User

12.4.2 South Korea

12.4.2.1 South Korea Autoimmune Disease Market by Product Type

12.4.2.2 South Korea Autoimmune Disease Market by Test Type

12.4.2.3 South Korea Autoimmune Disease Market by Disease Type

12.4.2.4 South Korea Autoimmune Disease Market by End User

12.4.3 China

12.4.3.1 China Autoimmune Disease Market by Product Type

12.4.3.2 China Autoimmune Disease Market by Test Type

12.4.3.3 China Autoimmune Disease Market by Disease Type

12.4.3.4 China Autoimmune Disease Market by End User

12.4.4 India

12.4.4.1 India Autoimmune Disease Market by Product Type

12.4.4.2 India Autoimmune Disease Market by Test Type

12.4.4.3 India Autoimmune Disease Market by Disease Type

12.5.4.4 India Autoimmune Disease Market by End User

12.4.5 Australia

12.4.5.1 Australia Autoimmune Disease Market by Product Type

12.4.5.2 Australia Autoimmune Disease Market by Test Type

12.4.5.3 Australia Autoimmune Disease Market by Disease Type

12.4.5.4 Australia Autoimmune Disease Market by End User

12.4.6 Rest of Asia-Pacific

12.4.6.1 APAC Autoimmune Disease Market by Product Type

12.4.6.2 APAC Autoimmune Disease Market by Test Type

12.4.6.3 APAC Autoimmune Disease Market by Disease Type

12.4.6.4 APAC Autoimmune Disease Market by End User

12.5 The Middle East & Africa

12.5.1 Israel

12.5.1.1 Israel Autoimmune Disease Market by Product Type

12.5.1.2 Israel Autoimmune Disease Market by Test Type

12.5.1.3 Israel Autoimmune Disease Market by Disease Type

12.5.1.4 Israel Autoimmune Disease Market by End User

12.5.2 UAE

12.5.2.1 UAE Autoimmune Disease Market by Product Type

12.5.2.2 UAE Autoimmune Disease Market by Test Type

12.5.2.3 UAE Autoimmune Disease Market by Disease Type

12.5.2.4 UAE Autoimmune Disease Market by End User

12.5.3 South Africa

12.5.3.1 South Africa Autoimmune Disease Market by Product Type

12.5.3.2 South Africa Autoimmune Disease Market by Test Type

12.5.3.3 South Africa Autoimmune Disease Market by Disease Type

12.5.3.4 South Africa Autoimmune Disease Market by End User

12.5.4 Rest of Middle East & Africa

12.5.4.1 Rest of Middle East & Asia Autoimmune Disease Market by Product Type

12.5.4.2 Rest of Middle East & Asia Autoimmune Disease Market by Test Type

12.5.4.3 Rest of Middle East & Asia Autoimmune Disease Market by Disease Type

12.5.4.4 Rest of Middle East & Asia Autoimmune Disease Market by End User

12.6 Latin America

11.6.1 Brazil

11.6.1.1 South Africa Autoimmune Disease Market by Product Type

12.6.1.2 South Africa Autoimmune Disease Market by Test Type

12.6.1.3 South Africa Autoimmune Disease Market by Disease Type

12.6.1.4 South Africa Autoimmune Disease Market by End User

11.6.2 Argentina

11.6.2.1 South Africa Autoimmune Disease Market by Product Type

12.6.2.2 South Africa Autoimmune Disease Market by Test Type

12.6.2.3 South Africa Autoimmune Disease Market by Disease Type

12.6.2.4 South Africa Autoimmune Disease Market by End User

12.6.3 Rest of Latin America

12.6.3.1 Mexico Autoimmune Disease Market by Product Type

12.6.3.2 Mexico Autoimmune Disease Market by Test Type

12.6.3.3 Mexico Autoimmune Disease Market by Disease Type

12.6.3.4 Mexico Autoimmune Disease Market by End User   

 

13 Company Profile

13.1 Siemens

13.1.1 Market Overview

13.1.2 Financials

13.1.3 Product/Services/Offerings

13.1.4 SWOT Analysis

13.1.5 The SNS View

 

13.2 Abbott

13.2.1 Market Overview

13.2.2 Financials

13.2.3 Product/Services/Offerings

13.2.4 SWOT Analysis

13.2.5 The SNS View

 

13.3 Thermos Fisher Scientific

13.3.1 Market Overview

13.3.2 Financials

13.3.3 Product/Services/Offerings

12.3.4 SWOT Analysis

13.3.5 The SNS View

 

13.4 Danaher

13.4.1 Market Overview

13.4.2 Financials

13.4.3 Product/Services/Offerings

13.4.4 SWOT Analysis

13.4.5 The SNS View

 

13.5 Bio Rad Laboratories

13.5.1 Market Overview

13.5.2 Financials

13.5.3 Product/Services/Offerings

13.5.4 SWOT Analysis

13.5.5 The SNS View

 

13.6 Grifols

13.6.1 Market Overview

13.6.2 Financials

13.6.3 Product/Services/Offerings

13.6.4 SWOT Analysis

13.6.5 The SNS View

 

13.7 Trinity Biotech

13.7.1 Market Overview

13.7.2 Financials

13.7.3 Product/Services/Offerings

13.7.4 SWOT Analysis

13.7.5 The SNS View

 

13.8 Werven

13.8.1 Market Overview

13.8.2 Financials

13.8.3 Product/Services/Offerings

13.8.4 SWOT Analysis

13.8.5 The SNS View

 

13.9 Cronus

13.9.1 Market Overview

13.9.2 Financials

13.9.3 Product/Services/Offerings

13.9.4 SWOT Analysis

13.9.5 The SNS View

 

13.10 Cambridge Life Sciences Limited .

13.10.1 Market Overview

13.10.2 Financials

13.10.3 Product/Services/Offerings

13.10.4 SWOT Analysis

13.10.5 The SNS View

 

13.11 HTG Molecular Diagnostics

13.11.1 Market Overview

13.11.2 Financials

13.11.3 Product/Services/Offerings

13.11.4 SWOT Analysis

13.11.5 The SNS View

 

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share Analysis

14.3 Recent Developments

 

15 Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.